IOI OLEO GMBH

See the poster by RCPE and IOI Oleo: Lipids: Enormous potential impaired with tough challenges This work investigates the solid-state...

IOI Oleo launched a new family of functional, lipid-based excipients, the polyglycerol esters at CPhI 2025. As the CPhI 2026...

LipoGalen™ 144 – The innovative new base for ovules and suppositories The innovative new base for ovules and suppositories Novelty...

Abstract Drug delivery via aerosolization is a non-invasive and ideal method for targeting the pulmonary system, achieving localized effect. This study aims...

Abstract Mucopolysaccharidosis type I (MPS-I) is a rare, multisystemic lysosomal storage disease (LSD) caused by mutations in the IDUA gene, which encodes...

Abstract High drug-loaded immediate-release formulations can be produced using a solvent-free and continuous melt-granulation method with a twin-screw extruder. Known...

Abstract Tolcapone is a nitrocatechol-based drug used as adjuvant therapy in Parkinson’s Disease (PD). Despite being effective in managing PD-associated...

Abstract Macrophages, as cells of the innate immune response, are involved in the pathology of various medical conditions (tumors, intracellular...

Abstract 3D printing drug formulations for personalized medicine is a growing research field and offers many opportunities to improve patient...

This poster has been presented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, which took place in...